The importance of early phase research

被引:29
作者
Aickin, Mikel
机构
[1] Univ Arizona, Dept Family & Community Med, Tucson, AZ USA
[2] Univ Arizona, Program Integrat Med, Tucson, AZ USA
[3] Natl Coll Nat Med, Helfgott Res Inst, Portland, OR USA
关键词
D O I
10.1089/acm.2007.6370
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Early phase research in complementary and alternative medicine (CAM) is especially important because of the large influence it has on the subsequent expenditure of money and effort in particular areas of CAM therapies. The culture of biomedical research has, however, blurred the distinction between early and late-phase research, and this has distorted the very distinct aims of these two activities. The purpose of this paper is to reaffirm the critical role of early phase CAM research. and to encourage CAM researchers to value and conduct early phase studies for their proper purposes.
引用
收藏
页码:447 / 450
页数:4
相关论文
共 9 条
[1]  
Aickin M., 2004, Evid-Based Integr Med, V1, P225, DOI [10.2165/01197065-200401040-00001, DOI 10.2165/01197065-200401040-00001]
[2]   Evidence-based complementary and alternative medicine: Back to basics [J].
Hammerschlag, Richard ;
Zwickey, Heather .
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2006, 12 (04) :349-350
[3]  
Hicks SM, 2004, J ALTERN COMPLEM MED, V10, P925, DOI 10.1089/acm.2004.10.925
[4]  
*I MED, 2005, COMPL ALT MED CAM US, pCH4
[5]   ETHICAL ISSUES IN PHASE-I ONCOLOGY RESEARCH - A COMPARISON OF INVESTIGATORS AND INSTITUTIONAL REVIEW BOARD CHAIRPERSONS [J].
KODISH, E ;
STOCKING, C ;
RATAIN, MJ ;
KOHRMAN, A ;
SIEGLER, M .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (11) :1810-1816
[6]  
MacPherson H, 2004, J ALTERN COMPLEM MED, V10, P1083
[7]   Clinical cross-over trials in phase I [J].
Senn, S ;
Ezzet, F .
STATISTICAL METHODS IN MEDICAL RESEARCH, 1999, 8 (03) :263-278
[8]   Analysis of pilot and early phase studies with small sample sizes [J].
Shih, WJ ;
Ohman- Strickland, PA ;
Lin, Y .
STATISTICS IN MEDICINE, 2004, 23 (12) :1827-1842
[9]  
Vickers Andrew J, 2006, J Soc Integr Oncol, V4, P46